Locations:

Tag: PCSK9 inhibitors

21-HVI-2500365_LDL-cholesterol-particles_650x450

October 26, 2021/Heart, Vascular and Thoracic/Preventive Cardiology

Statin Intolerance and New Lipid-Lowering Treatments

Updated guidance on identification and strategies for management

March 18, 2019/Heart, Vascular and Thoracic/Insight & Perspectives

Statin Intolerance: Pearls for Practice in the PCSK9 Inhibitor Era

Q&A with the director of our dedicated program for statin intolerance

November 15, 2016/Heart, Vascular and Thoracic/Research

First IVUS Study of a PCSK9 Inhibitor Shows Atheroma Regression at Unprecedented LDL-C Levels

GLAGOV results boost hopes for coming outcome trials

August 18, 2015/Heart, Vascular and Thoracic/News & Insights

Approval of First PCSK9 Inhibitor Marks New Era (Video)

How it fits into today’s cholesterol-lowering practice

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 12, 2015/Heart, Vascular and Thoracic/Research

PCSK9 Inhibitors Edge Closer to FDA Approval

A new option for patients who need more than statins

BackPage 1 of 1Next